Net Medical Xpress Solutions (OTCMKTS:NMXS) Stock Jumps After Key Announcement
Net Medical Xpress Solutions (OTCMKTS:NMXS) was up 8% after stating that it is offering a Gold Standard PCR test to New Mexico for ordinary flu, colds, COVID and other related upper respiratory infections.
Market Stats
On Wednesday, NMXS stock moved up 7.69 to $0.0700 with more than 57.7k shares, compared to its average volume of 12.88k shares. The stock moved within a range of $0.0650 – 0.0724 after opening trading at $0.0650.
Net Medical’s Upper Respiratory Test Identifies COVID, Flu and the Common Cold; More States To Be Added
The company now provides bioMerieux’s patented PCR testing modules through mobile vans in Albuquerque and Taos, making it quick, economical, and simple for individuals afflicted to receive a definitive notion of the sickness they may be facing. In addition, the test results are useful to authorities facilitating job interviews, going to the workplace and travelling activities easier.
The pilot program was so successful in the state, and the company now wants to replicate the program in other states. CEO Dick Govatski stated that the rollout of their respiratory testing vans demonstrated tremendous success. In addition, he said that the company had witnessed high volumes for individuals after knowing their health status. Due to the COVID-19 pandemic, there is a growing need for information regarding the health status of people. So in the coming weeks, NMXS is worth watching.
Key Quote
Net Medical CEO Dick Govatski said, “The roll out of our respiratory testing vans has been an enormous success. We have experienced high volumes of those seeking definitive information about their health status.
Traders Corner
NMXS stock is trading above the 20-Day and 50-Day Moving averages of $0.0646 and $0.0643 respectively. The stock is trading in the neutral zone with RSI stands at 53.
